SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-002737
Filing Date
2024-01-08
Accepted
2024-01-08 09:00:09
Documents
12
Period of Report
2024-01-08
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K igms-20240108.htm   iXBRL 8-K 36899
  Complete submission text file 0000950170-24-002737.txt   153443

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igms-20240108.xsd EX-101.SCH 2451
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igms-20240108_pre.xml EX-101.PRE 9828
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igms-20240108_lab.xml EX-101.LAB 13342
6 EXTRACTED XBRL INSTANCE DOCUMENT igms-20240108_htm.xml XML 4709
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39045 | Film No.: 24518589
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)